A	O
novel	O
heterodimerization	B-protein
partner	I-protein
for	O
thyroid	B-protein
hormone	I-protein
receptor	I-protein
.	O

Peroxisome	B-protein
proliferator-activated	I-protein
receptor	I-protein
.	O

Retinoid-like	B-protein
receptors	I-protein
play	O
a	O
central	O
role	O
in	O
hormonal	O
responses	O
by	O
forming	O
heterodimers	B-protein
with	O
other	O
nuclear	B-protein
hormone	I-protein
receptors	I-protein
.	O

In	O
this	O
study	O
we	O
have	O
identified	O
the	O
peroxisome	B-protein
proliferator-activated	I-protein
receptor	I-protein
(	O
PPAR	B-protein
)	O
as	O
a	O
new	O
thyroid	B-protein
hormone	I-protein
receptor	I-protein
(	I-protein
THR	I-protein
)	I-protein
auxiliary	I-protein
nuclear	I-protein
protein	I-protein
,	O
heterodimerizing	O
with	O
THR	B-protein
in	O
solution	O
.	O

Although	O
these	O
heterodimers	B-protein
do	O
not	O
recognize	O
a	O
classical	O
thyroid	B-DNA
hormone	I-DNA
response	I-DNA
element	I-DNA
(	O
TRE	B-DNA
)	O
characterized	O
by	O
direct	O
repeat	O
separated	O
by	O
four	O
nucleotides	O
(	O
DR+4	B-DNA
)	O
,	O
PPAR	B-protein
behaves	O
as	O
a	O
dominant	O
negative	O
regulator	O
of	O
thyroid	O
hormone	O
(	O
TH	O
)	O
action	O
.	O

However	O
,	O
a	O
TH-dependent	O
positive	O
effect	O
is	O
elicited	O
by	O
selective	O
interaction	O
of	O
the	O
THR	B-protein
beta-PPAR	I-protein
but	O
not	O
the	O
THR	B-protein
alpha-PPAR	I-protein
heterodimer	I-protein
with	O
a	O
novel	O
TRE	B-DNA
(	O
DR+2	B-DNA
)	O
.	O

The	O
critical	O
region	O
of	O
THR	B-protein
beta	O
was	O
mapped	O
to	O
3	O
amino	O
acids	O
in	O
the	O
distal	B-protein
box	I-protein
of	O
the	O
DNA	B-protein
binding	I-protein
domain	I-protein
.	O

Hence	O
,	O
PPAR	B-protein
can	O
positively	O
or	O
negatively	O
influence	O
TH	O
action	O
depending	O
on	O
TRE	B-DNA
structure	O
and	O
THR	B-protein
isotype	I-protein
.	O

Communication	NULL
A	NULL
Novel	NULL
Heterodimerization	NULL
Partner	NULL
for	NULL
Thyroid	NULL
Hormone	NULL
Receptor	NULL
PEROXISOME	NULL
PROLIFERATOR-ACTIVATED	NULL
RECEPTOR*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
26	NULL
,	NULL
1994	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
February	NULL
11	NULL
,	NULL
1994	NULL
)	NULL
Fausto	NULL
Bogazzi	NULL
,	NULL
Lynn	NULL
D.	NULL
Hudson	NULL
}	NULL
,	NULL
and	NULL
Vera	NULL
M.	NULL
Nikodem	NULL
{	NULL
ยง	NULL
From	NULL
the	NULL
Genetics	NULL
and	NULL
Biochemistry	NULL
Branch	NULL
,	NULL
Mechanisms	NULL
of	NULL
Gene	NULL
Regulation	NULL
Section	NULL
,	NULL
NIDDK	NULL
and	NULL
the	NULL
{	NULL
Laboratory	NULL
of	NULL
Viral	NULL
and	NULL
Molecular	NULL
Pathogenesis	NULL
,	NULL
NINDS	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
Retinoid-like	NULL
receptors	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
hormonal	NULL
responses	NULL
by	NULL
forming	NULL
heterodimers	NULL
with	NULL
other	NULL
nuclear	NULL
hormone	NULL
receptors	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
identified	NULL
the	NULL
peroxisome	NULL
proliferator-activated	NULL
receptor	NULL
(	NULL
PPAR	NULL
)	NULL
as	NULL
a	NULL
new	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
(	NULL
THR	NULL
)	NULL
auxiliary	NULL
nuclear	NULL
protein	NULL
,	NULL
heterodimerizing	NULL
with	NULL
THR	NULL
in	NULL
solution	NULL
.	NULL

Although	NULL
these	NULL
heterodimers	NULL
do	NULL
not	NULL
recognize	NULL
a	NULL
classical	NULL
thyroid	NULL
hormone	NULL
response	NULL
element	NULL
(	NULL
TRE	NULL
)	NULL
characterized	NULL
by	NULL
direct	NULL
repeat	NULL
separated	NULL
by	NULL
four	NULL
nucleotides	NULL
(	NULL
DR	NULL
+	NULL
4	NULL
)	NULL
,	NULL
PPAR	NULL
behaves	NULL
as	NULL
a	NULL
dominant	NULL
negative	NULL
regulator	NULL
of	NULL
thyroid	NULL
hormone	NULL
(	NULL
TH	NULL
)	NULL
action	NULL
.	NULL

However	NULL
,	NULL
a	NULL
TH-dependent	NULL
positive	NULL
effect	NULL
is	NULL
elicited	NULL
by	NULL
selective	NULL
interaction	NULL
of	NULL
the	NULL
THRG-PPAR	NULL
but	NULL
not	NULL
the	NULL
THRa-PPAR	NULL
heterodimer	NULL
with	NULL
a	NULL
novel	NULL
TRE	NULL
(	NULL
DR	NULL
+	NULL
2	NULL
)	NULL
.	NULL

The	NULL
critical	NULL
region	NULL
of	NULL
THRB	NULL
was	NULL
mapped	NULL
to	NULL
3	NULL
amino	NULL
acids	NULL
in	NULL
the	NULL
distal	NULL
box	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Hence	NULL
,	NULL
PPAR	NULL
can	NULL
positively	NULL
or	NULL
negatively	NULL
influence	NULL
TH	NULL
action	NULL
depending	NULL
on	NULL
TRE	NULL
structure	NULL
and	NULL
THR	NULL
isotype	NULL
.	NULL

The	NULL
diversity	NULL
provided	NULL
by	NULL
heterodimerization	NULL
within	NULL
the	NULL
subfamily	NULL
of	NULL
nuclear	NULL
hormone	NULL
receptors	NULL
offers	NULL
additional	NULL
levels	NULL
of	NULL
regulation	NULL
.	NULL

In	NULL
a	NULL
hormone-dependent	NULL
manner	NULL
the	NULL
RXR'-contain-ing	NULL
heterodimers	NULL
modulate	NULL
transcription	NULL
of	NULL
target	NULL
genes	NULL
via	NULL
hormone	NULL
response	NULL
elements	NULL
arranged	NULL
as	NULL
DR	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
spacer	NULL
length	NULL
between	NULL
these	NULL
repeats	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
achieving	NULL
selective	NULL
hormonal	NULL
responses	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
spacing	NULL
of	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
nucleotides	NULL
is	NULL
recognized	NULL
by	NULL
heterodimers	NULL
of	NULL
RXR	NULL
with	NULL
vitamin	NULL
D	NULL
receptor	NULL
,	NULL
THR	NULL
,	NULL
and	NULL
retinoic	NULL
acid	NULL
receptor	NULL
,	NULL
respectively	NULL
(	NULL
2-7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
degeneracy	NULL
of	NULL
this	NULL
spacer	NULL
rule	NULL
has	NULL
been	NULL
sug-gested	NULL
,	NULL
since	NULL
RXR-retinoic	NULL
acid	NULL
receptor	NULL
heterodimers	NULL
can	NULL
also	NULL
*	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

ยง	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Bldg	NULL
.	NULL

10	NULL
,	NULL
Rm	NULL
.	NULL

8N315	NULL
,	NULL
NIH	NULL
,	NULL
9000	NULL
Rockville	NULL
Pike	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
301-496-0944	NULL
;	NULL
Fax	NULL
:	NULL
301-402-0387	NULL
.	NULL
'	NULL

The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
RXR	NULL
,	NULL
retinoid-like	NULL
receptor	NULL
;	NULL
PPAR	NULL
,	NULL
peroxisome	NULL
proliferator-activated	NULL
receptor	NULL
;	NULL
THR	NULL
,	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
;	NULL
TRE	NULL
,	NULL
thyroid	NULL
hormone	NULL
response	NULL
element	NULL
;	NULL
DR	NULL
,	NULL
direct	NULL
repeat	NULL
(	NULL
s	NULL
)	NULL
;	NULL
RSV	NULL
,	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
;	NULL
CMV	NULL
,	NULL
cytomegalovirus	NULL
;	NULL
TSH	NULL
,	NULL
thyrotropin	NULL
;	NULL
TH	NULL
,	NULL
thyroid	NULL
hormone	NULL
;	NULL
D	NULL
,	NULL
distal	NULL
;	NULL
DBD	NULL
,	NULL
DNA	NULL
binding	NULL
domain	NULL
;	NULL
LBD	NULL
,	NULL
ligand	NULL
binding	NULL
domain	NULL
;	NULL
PLP	NULL
,	NULL
myelin	NULL
proteolipid	NULL
protein	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
TK	NULL
,	NULL
thymidine	NULL
kinase	NULL
;	NULL
wt	NULL
,	NULL
wild	NULL
type	NULL
;	NULL
chim	NULL
,	NULL
chimeric	NULL
receptor	NULL
(	NULL
s	NULL
)	NULL
;	NULL
ME	NULL
,	NULL
malic	NULL
enzyme	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Tez	NULL
Journat	NULL
or	NULL
Brotoctcat	NULL
Caenistay	NULL
Vol	NULL
.	NULL

269	NULL
,	NULL
No	NULL
.	NULL

16	NULL
,	NULL
Issue	NULL
of	NULL
April	NULL
22	NULL
,	NULL
pp	NULL
.	NULL

11683-11686	NULL
,	NULL
1994	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
activate	NULL
genes	NULL
through	NULL
DR	NULL
+	NULL
1	NULL
and	NULL
DR	NULL
+	NULL
2	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
DR	NULL
+	NULL
1	NULL
element	NULL
conveys	NULL
clofibrate-dependent	NULL
transactivation	NULL
,	NULL
mediated	NULL
by	NULL
PPAR-RXR	NULL
heterodimers	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
underlying	NULL
these	NULL
promiscuous	NULL
interactions	NULL
is	NULL
unknown	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
within	NULL
this	NULL
subfamily	NULL
more	NULL
than	NULL
one	NULL
RXR-like	NULL
heterodimerization	NULL
partner	NULL
with	NULL
different	NULL
heterodimerization	NULL
specificity	NULL
may	NULL
exist	NULL
.	NULL

THR	NULL
and	NULL
PPAR	NULL
appear	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
lipid	NULL
metabolism	NULL
,	NULL
and	NULL
,	NULL
thus	NULL
,	NULL
their	NULL
signaling	NULL
pathways	NULL
might	NULL
be	NULL
coupled	NULL
.	NULL

Hence	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
possibility	NULL
that	NULL
PPAR	NULL
might	NULL
be	NULL
another	NULL
THR	NULL
auxiliary	NULL
nuclear	NULL
protein	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
describe	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
THR-PPAR	NULL
heterodimers	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
classical	NULL
TRE	NULL
(	NULL
DR	NULL
+	NULL
4	NULL
)	NULL
and	NULL
a	NULL
newly	NULL
described	NULL
TRE	NULL
(	NULL
DR	NULL
+	NULL
2	NULL
)	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
and	NULL
Preparation	NULL
of	NULL
in	NULL
Vitro	NULL
Translated	NULL
Receptors-The	NULL
RSV	NULL
rat	NULL
THRa	NULL
,	NULL
rat	NULL
THRB	NULL
,	NULL
and	NULL
RSV	NULL
mouse	NULL
RXR	NULL
$	NULL
expression	NULL
plasmids	NULL
have	NULL
been	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
plasmid	NULL
CMV	NULL
,	NULL
PPAR	NULL
containing	NULL
the	NULL
rat	NULL
PPAR	NULL
cDNA	NULL
subcloned	NULL
in	NULL
the	NULL
BamHI/BgiII	NULL
sites	NULL
of	NULL
CMV	NULL
,	NULL
expression	NULL
vector	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
F.	NULL
Gonzales	NULL
.	NULL

The	NULL
reporter	NULL
plasmid	NULL
PJBO42-CAT	NULL
containing	NULL
the	NULL
human	NULL
myelin	NULL
proteolipid	NULL
protein	NULL
(	NULL
PLP	NULL
)	NULL
gene	NULL
promoter	NULL
sequence	NULL
(	NULL
-312/+85	NULL
)	NULL
and	NULL
chloramphenicol	NULL
acetyl-transferase	NULL
(	NULL
CAT	NULL
)	NULL
coding	NULL
sequence	NULL
has	NULL
been	NULL
described	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
constructs	NULL
malic	NULL
enzyme	NULL
(	NULL
ME	NULL
)	NULL
-TRE-TK-CAT	NULL
and	NULL
TSHG-TRE-TK-CAT	NULL
were	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
construct	NULL
PLP-TRE	NULL
wild	NULL
type	NULL
(	NULL
wt	NULL
)	NULL
TK-CAT	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
PLP	NULL
gene	NULL
sequence	NULL
at	NULL
position	NULL
-10/+52	NULL
(	NULL
TGTCAATCAGAAAGCCCTTTTCATTGCAGGAGAAGAGGACAAAG-ATACTCAGAGAGAAAAAG	NULL
)	NULL
in	NULL
restriction	NULL
sites	NULL
of	NULL
pBLCAT	NULL
2	NULL
vector	NULL
.	NULL

The	NULL
direct	NULL
repeats	NULL
on	NULL
the	NULL
sequence	NULL
of	NULL
PLP-TRE	NULL
are	NULL
underlined	NULL
.	NULL

The	NULL
reporter	NULL
construct	NULL
PLP-TRE	NULL
mutated	NULL
TK-CAT	NULL
contains	NULL
mutations	NULL
(	NULL
G	NULL
;	NULL
-	NULL
>	NULL
Ty	NULL
,	NULL
C	NULL
,	NULL
-	NULL
>	NULL
A	NULL
;	NULL
)	NULL
in	NULL
direct	NULL
repeats	NULL
only	NULL
.	NULL

Identity	NULL
of	NULL
PLP-TRE	NULL
,	NULL
wt	NULL
or	NULL
mutated	NULL
,	NULL
was	NULL
confirmed	NULL
by	NULL
sequencing	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Thyroid	NULL
hormone	NULL
chimeric	NULL
receptors	NULL
(	NULL
chim	NULL
)	NULL
1-4	NULL
were	NULL
constructed	NULL
using	NULL
the	NULL
recombinant	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
.	NULL

For	NULL
the	NULL
primary	NULL
reactions	NULL
,	NULL
specific	NULL
oligonucleotide	NULL
primers	NULL
were	NULL
designed	NULL
.	NULL

The	NULL
external	NULL
primers	NULL
had	NULL
sequences	NULL
complementary	NULL
to	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
THRa	NULL
(	NULL
chim	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
THR	NULL
$	NULL
(	NULL
chim	NULL
3	NULL
and	NULL
4	NULL
)	NULL
and	NULL
carried	NULL
at	NULL
their	NULL
5'-ends	NULL
an	NULL
internal	NULL
HindIII	NULL
recognition	NULL
sequence	NULL
.	NULL

The	NULL
other	NULL
external	NULL
primers	NULL
were	NULL
complementary	NULL
to	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
THR	NULL
$	NULL
(	NULL
chim	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
4	NULL
)	NULL
or	NULL
THRe	NULL
(	NULL
chim	NULL
3	NULL
)	NULL
and	NULL
carried	NULL
at	NULL
their	NULL
3'-ends	NULL
the	NULL
pal	NULL
recognition	NULL
sequence	NULL
.	NULL

Appropriate	NULL
internal	NULL
primers	NULL
were	NULL
designed	NULL
for	NULL
each	NULL
chimeric	NULL
receptor	NULL
.	NULL

Internal	NULL
primers	NULL
had	NULL
the	NULL
sequence	NULL
of	NULL
both	NULL
junction	NULL
regions	NULL
to	NULL
generate	NULL
sticky	NULL
ends	NULL
for	NULL
a	NULL
subsequent	NULL
annealing	NULL
.	NULL

The	NULL
products	NULL
of	NULL
the	NULL
primary	NULL
PCR	NULL
reaction	NULL
were	NULL
purified	NULL
,	NULL
an-nealed	NULL
,	NULL
and	NULL
used	NULL
as	NULL
templates	NULL
in	NULL
a	NULL
secondary	NULL
PCR	NULL
reaction	NULL
together	NULL
with	NULL
both	NULL
external	NULL
primers	NULL
to	NULL
generate	NULL
the	NULL
final	NULL
chimeras	NULL
.	NULL

PCR	NULL
reactions	NULL
were	NULL
performed	NULL
as	NULL
suggested	NULL
by	NULL
the	NULL
supplier	NULL
(	NULL
Perkin-Elmer	NULL
)	NULL
.	NULL

After	NULL
25	NULL
cycles	NULL
of	NULL
amplification	NULL
(	NULL
denaturation	NULL
,	NULL
1	NULL
min	NULL
,	NULL
94	NULL
ยฐC	NULL
;	NULL
annealing	NULL
,	NULL
1	NULL
min	NULL
,	NULL
55	NULL
ยฐC	NULL
;	NULL
extension	NULL
,	NULL
45	NULL
s	NULL
,	NULL
72	NULL
ยฐC	NULL
)	NULL
the	NULL
final	NULL
reaction	NULL
products	NULL
were	NULL
purified	NULL
on	NULL
low	NULL
melting	NULL
point	NULL
agarose	NULL
gel	NULL
and	NULL
subcloned	NULL
into	NULL
HindIIl/Hpal	NULL
sites	NULL
of	NULL
the	NULL
expression	NULL
plasmid	NULL
RSV	NULL
Aneo	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
chimeric	NULL
receptors	NULL
was	NULL
confirmed	NULL
by	NULL
sequencing	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Each	NULL
chimeric	NULL
receptor	NULL
was	NULL
capable	NULL
of	NULL
mediating	NULL
TH-dependent	NULL
activation	NULL
of	NULL
ME-TRE-TK-CAT	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
translated	NULL
receptors	NULL
were	NULL
prepared	NULL
using	NULL
pSP72	NULL
vector	NULL
containing	NULL
either	NULL
a	NULL
rat	NULL
THRa	NULL
,	NULL
THR	NULL
$	NULL
,	NULL
or	NULL
PPAR	NULL
cDNA	NULL
sequence	NULL
,	NULL
and	NULL
unlabeled	NULL
or	NULL
[	NULL
ยฐ*ยฐS	NULL
]	NULL
Met-labeled	NULL
receptors	NULL
were	NULL
produced	NULL
from	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
according	NULL
to	NULL
the	NULL
supplier	NULL
's	NULL
instructions	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Efficiency	NULL
of	NULL
translation	NULL
was	NULL
similar	NULL
for	NULL
any	NULL
cDNA	NULL
as	NULL
estimated	NULL
by	NULL
SDS	NULL
gel	NULL
elec-trophoresis	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Transfection	NULL
Assays-NIH3T3	NULL
and	NULL
NG108-15	NULL
cells	NULL
were	NULL
grown	NULL
as	NULL
described	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Transfection	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
Gene-Pulser	NULL
Electroporator	NULL
(	NULL
Bio-Rad	NULL
)	NULL
as	NULL
described	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
25	NULL
ug	NULL
of	NULL
a	NULL
reporter	NULL
plasmid	NULL
was	NULL
electroporated	NULL
into	NULL
NIH3T3	NULL
or	NULL
NG108-15	NULL
cells	NULL
(	NULL
4.2	NULL
x	NULL
10ยฐ	NULL
)	NULL
with	NULL
12.5	NULL
ug	NULL
of	NULL
either	NULL
RSV-THRa	NULL
,	NULL
RSV-THRS	NULL
,	NULL
RSV-RXRf	NULL
,	NULL
CMV	NULL
,	NULL
-PPAR	NULL
expression	NULL
plasmid	NULL
,	NULL
or	NULL
any	NULL
combination	NULL
of	NULL
two	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
6.25	NULL
ug	NULL
of	NULL
CMV	NULL
,	NULL
-PPAR	NULL
expression	NULL
plasmid	NULL
was	NULL
used	NULL
;	NULL
1	NULL
ug	NULL
of	NULL
CMV	NULL
,	NULL
-8	NULL
galactosidase	NULL
was	NULL
added	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

The	NULL
cells	NULL
11683	NULL
11684	NULL
THR	NULL
a	NULL
THR	NULL
B	NULL
THR	NULL
a	NULL
+	NULL
RXR	NULL
B	NULL
THR	NULL
B+	NULL
RXR	NULL
B	NULL
RXR	NULL
B	NULL
THR	NULL
a	NULL
+	NULL
PPAR	NULL
THR	NULL
B+	NULL
PPAR	NULL
PPAR	NULL
I	NULL
-	NULL
r	NULL
--	NULL
-	NULL
-	NULL
t	NULL
-	NULL
(	NULL
=-0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
CAT	NULL
activity	NULL
(	NULL
fold	NULL
induction	NULL
)	NULL
Vector	NULL
THR	NULL
B	NULL
+	NULL
PPAR	NULL
Mur-TRE	NULL
WeTRE	NULL
0	NULL
D	NULL
2	NULL
3	NULL
4	NULL
CAT	NULL
activity	NULL
(	NULL
+TH	NULL
/-TH	NULL
)	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Thyroid	NULL
hormone-dependent	NULL
activity	NULL
of	NULL
the	NULL
PLP	NULL
pro-moter	NULL
.	NULL

Transient	NULL
transfection	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
PLP-312/	NULL
+85-promoter-CAT	NULL
reporter	NULL
(	NULL
A	NULL
)	NULL
or	NULL
a	NULL
synthetic	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
wt	NULL
or	NULL
mutated	NULL
sequence	NULL
of	NULL
PLP-10+52-TRE	NULL
upstream	NULL
from	NULL
TK	NULL
promoter	NULL
(	NULL
PLP-TRE-TK-CAT	NULL
)	NULL
or	NULL
the	NULL
vector	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Source	NULL
of	NULL
plasmids	NULL
,	NULL
construction	NULL
of	NULL
the	NULL
reporter	NULL
genes	NULL
,	NULL
and	NULL
transfection	NULL
assays	NULL
were	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Expression	NULL
plasmids	NULL
RSV-THRa	NULL
ยซ	NULL
,	NULL
-THRB	NULL
,	NULL
-RXR	NULL
$	NULL
,	NULL
and	NULL
CMV	NULL
,	NULL
-PPAR	NULL
in	NULL
the	NULL
indicated	NULL
combinations	NULL
were	NULL
electroporated	NULL
in	NULL
NIH3T3	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
either	NULL
a	NULL
single	NULL
cognate	NULL
ligand	NULL
or	NULL
both	NULL
ligands	NULL
or	NULL
Wy	NULL
14,643	NULL
activator	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
a	NULL
ratio	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
the	NULL
ligand	NULL
(	NULL
s	NULL
)	NULL
or	NULL
activator	NULL
.	NULL

were	NULL
equally	NULL
divided	NULL
into	NULL
four	NULL
60-mm	NULL
dishes	NULL
,	NULL
two	NULL
of	NULL
which	NULL
contained	NULL
no	NULL
ligand	NULL
while	NULL
the	NULL
other	NULL
two	NULL
received	NULL
either	NULL
a	NULL
single	NULL
ligand	NULL
(	NULL
1	NULL
x	NULL
10~	NULL
m	NULL
TH	NULL
(	NULL
3,5,3'-triiodothyronine	NULL
)	NULL
,	NULL
1	NULL
x	NULL
10~ยฐ	NULL
m	NULL
9-cis-retinoic	NULL
acid	NULL
)	NULL
or	NULL
activator	NULL
(	NULL
1	NULL
x	NULL
10~*	NULL
Wy	NULL
14,643	NULL
)	NULL
or	NULL
both	NULL
ligands	NULL
or	NULL
the	NULL
activator	NULL
.	NULL

The	NULL
CAT	NULL
and	NULL
B-galac-tosidase	NULL
activities	NULL
were	NULL
determined	NULL
72	NULL
h	NULL
later	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Results	NULL
shown	NULL
in	NULL
this	NULL
study	NULL
were	NULL
obtained	NULL
using	NULL
NIH3T3	NULL
cells	NULL
and	NULL
represent	NULL
the	NULL
average	NULL
(	NULL
+8.D	NULL
.	NULL
)	NULL

of	NULL
five	NULL
experiments	NULL
,	NULL
each	NULL
of	NULL
them	NULL
carried	NULL
out	NULL
in	NULL
duplicate	NULL
.	NULL

NG108-15	NULL
cells	NULL
gave	NULL
similar	NULL
results	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Gel	NULL
Mobility	NULL
Shift	NULL
Assays-Expression	NULL
vector	NULL
pSP72	NULL
containing	NULL
cDNA	NULL
of	NULL
the	NULL
rat	NULL
PPARa	NULL
ยซ	NULL
,	NULL
THRa	NULL
ยซ	NULL
,	NULL
and	NULL
THRB	NULL
was	NULL
used	NULL
for	NULL
in	NULL
vitro	NULL
tran-scription-translation	NULL
.	NULL

THRB	NULL
overexpressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
and	NULL
purified	NULL
by	NULL
glutathione	NULL
S-transferase	NULL
affinity	NULL
chromatography	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
M.	NULL
Bagchi	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
Sf-9	NULL
cells	NULL
overexpressing	NULL
the	NULL
rat	NULL
THRa	NULL
or	NULL
mouse	NULL
RXR	NULL
were	NULL
used	NULL
as	NULL
a	NULL
source	NULL
of	NULL
these	NULL
receptors	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
unprogrammed	NULL
reticulocyte	NULL
lysate	NULL
and	NULL
Sf-9	NULL
wt	NULL
nuclear	NULL
extracts	NULL
were	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

The	NULL
human	NULL
PLP	NULL
-312/+85	NULL
fragment	NULL
was	NULL
obtained	NULL
by	NULL
digesting	NULL
the	NULL
PJBO42	NULL
plasmid	NULL
with	NULL
HindIII	NULL
restriction	NULL
endo-nuclease	NULL
,	NULL
purified	NULL
,	NULL
and	NULL
*ยฐP-labeled	NULL
using	NULL
T	NULL
,	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

The	NULL
-labeled	NULL
sequence	NULL
of	NULL
PLP-TRE	NULL
wt	NULL
(	NULL
+11/+44	NULL
)	NULL
was	NULL
5'TTCATTGCAG-GACAAGAGGACAAAGATACTCAGA3	NULL
'	NULL
;	NULL
mutated	NULL
PLP-TRE	NULL
had	NULL
mutations	NULL
as	NULL
indicated	NULL
above	NULL
.	NULL

The	NULL
rat	NULL
ME-TRE	NULL
has	NULL
been	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

For	NULL
the	NULL
binding	NULL
reaction	NULL
,	NULL
2.5	NULL
ul	NULL
of	NULL
each	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
translated	NULL
PPAR	NULL
,	NULL
THR	NULL
,	NULL
and	NULL
THR	NULL
$	NULL
or	NULL
2.5	NULL
ul	NULL
of	NULL
unprogrammed	NULL
reticulocyte	NULL
lysate	NULL
or	NULL
1	NULL
ul	NULL
of	NULL
Sf-9	NULL
nuclear	NULL
extracts	NULL
(	NULL
wt	NULL
or	NULL
containing	NULL
THRa	NULL
ยซ	NULL
or	NULL
RXR	NULL
$	NULL
)	NULL
or	NULL
0.2	NULL
ul	NULL
of	NULL
purified	NULL
THR	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
2.5	NULL
ul	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
PPAR	NULL
was	NULL
used	NULL
.	NULL

After	NULL
preincubation	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
ul	NULL
(	NULL
20	NULL
mm	NULL
Hepes	NULL
pH	NULL
7.9	NULL
,	NULL
0.5	NULL
my	NULL
dithiothreitol	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mm	NULL
EDTA	NULL
,	NULL
100	NULL
mm	NULL
KCl	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dA-dT	NULL
)	NULL
or	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
)	NULL
,	NULL
~3	NULL
ng	NULL
(	NULL
15,000	NULL
cpm	NULL
)	NULL
of	NULL
probe	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
incubation	NULL
continued	NULL
for	NULL
45	NULL
min	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
4-12	NULL
%	NULL
gradient	NULL
or	NULL
a	NULL
5	NULL
%	NULL
linear	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
0.5	NULL
x	NULL
TBE	NULL
(	NULL
45	NULL
mm	NULL
Tris	NULL
,	NULL
45	NULL
mm	NULL
boriยข	NULL
acid	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
)	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
at	NULL
-70	NULL
ยฐC	NULL
to	NULL
Hyperfilm-MP	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
with	NULL
intensifying	NULL
screen	NULL
.	NULL

Coimmunoprecipitation	NULL
Experiments-For	NULL
coimmunoprecipitation	NULL
experiments	NULL
,	NULL
5	NULL
ul	NULL
of	NULL
[	NULL
*S	NULL
)	NULL
Met-labeled	NULL
rat	NULL
PPAR	NULL
and/or	NULL
[	NULL
*S	NULL
}	NULL
Met-labeled	NULL
THRa	NULL
ยซ	NULL
,	NULL
THRB	NULL
,	NULL
and	NULL
PPAR	NULL
Heterodimer	NULL
Coupling	NULL
of	NULL
Signaling	NULL
Pathways	NULL
A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
unpr	NULL
.	NULL

lys	NULL
.	NULL

_	NULL
+	NULL
THR	NULL
o	NULL
.	NULL

+	NULL
+	NULL
+	NULL
THR	NULL
B	NULL
+	NULL
+	NULL
+	NULL
PPAR	NULL
+	NULL
+	NULL
+	NULL
4+	NULL
RXR	NULL
B	NULL
+	NULL
+o	NULL
++	NULL
Sf9	NULL
wt	NULL
+	NULL
-	NULL
ยป	NULL
B	NULL
unpr	NULL
.	NULL

lys	NULL
+	NULL
+	NULL
+	NULL
THR	NULL
$	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
PPAR	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
competitor	NULL
+	NULL
+	NULL
u	NULL
ยฅ	NULL
as	NULL
L	NULL
a	NULL
L	NULL
J	NULL
PROBE	NULL
PLP-TRE	NULL
wt	NULL
PLP-TRE-mut	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Formation	NULL
of	NULL
THRB-PPAR	NULL
heterodimers	NULL
on	NULL
PLP-TRE	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
either	NULL
a	NULL
PLP-312/+85	NULL
promoter	NULL
fragment	NULL
(	NULL
A	NULL
)	NULL
or	NULL
a	NULL
synthetic	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
wt	NULL
or	NULL
mutated	NULL
PLP-TRE	NULL
(	NULL
+11/+44	NULL
)	NULL
sequence	NULL
(	NULL
B	NULL
)	NULL
as	NULL
P-labeled	NULL
probes	NULL
.	NULL

Source	NULL
of	NULL
the	NULL
receptors	NULL
and	NULL
the	NULL
assay	NULL
were	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
receptors	NULL
THRB	NULL
,	NULL
PPAR	NULL
,	NULL
Sf-9	NULL
THRa	NULL
,	NULL
or	NULL
RXRB	NULL
were	NULL
used	NULL
in	NULL
the	NULL
combinations	NULL
as	NULL
shown	NULL
.	NULL

Complexes	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
5	NULL
%	NULL
linear	NULL
(	NULL
A	NULL
)	NULL
or	NULL
4-12	NULL
%	NULL
gradient	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

A	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
myelin	NULL
basic	NULL
protein-TRE	NULL
was	NULL
used	NULL
as	NULL
a	NULL
specific	NULL
competitor	NULL
.	NULL

unpr	NULL
.	NULL

Lys	NULL
,	NULL
unprogrammed	NULL
lysate	NULL
.	NULL

rat	NULL
THRa	NULL
ยซ	NULL
or	NULL
0.1	NULL
ul	NULL
of	NULL
unlabeled	NULL
rat	NULL
THRa	NULL
produced	NULL
in	NULL
Sf-9	NULL
cells	NULL
or	NULL
Sf-9	NULL
wt	NULL
extract	NULL
or	NULL
5	NULL
pil	NULL
of	NULL
unprogrammed	NULL
reticulocyte	NULL
lysate	NULL
were	NULL
incubated	NULL
for	NULL
60	NULL
min	NULL
at	NULL
4	NULL
ยฐC	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
various	NULL
combinations	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
1	NULL
x	NULL
binding	NULL
buffer	NULL
(	NULL
16	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
ul	NULL
of	NULL
polyclonal	NULL
antiserum	NULL
prepared	NULL
against	NULL
rat	NULL
THRa	NULL
ยซ	NULL
.	NULL

Antigen-antibody	NULL
complexes	NULL
were	NULL
precipitated	NULL
by	NULL
adding	NULL
50	NULL
ul	NULL
of	NULL
r-protein	NULL
G-agarose	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
and	NULL
the	NULL
immunocomplexes	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
100	NULL
ul	NULL
of	NULL
binding	NULL
buffer	NULL
.	NULL

The	NULL
complexes	NULL
were	NULL
then	NULL
resuspended	NULL
in	NULL
sample	NULL
buffer	NULL
(	NULL
Novex	NULL
)	NULL
,	NULL
boiled	NULL
,	NULL
resolved	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
autoradiographed	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
TH	NULL
responsiveness	NULL
of	NULL
a	NULL
human	NULL
PLP	NULL
promoter	NULL
-312/+85	NULL
CAT	NULL
reporter	NULL
was	NULL
tested	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
using	NULL
either	NULL
NIH3T3	NULL
or	NULL
NG108-15	NULL
cells	NULL
.	NULL

Neither	NULL
THRa	NULL
nor	NULL
THRB	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
RXRB	NULL
and	NULL
9-cis-retinoic	NULL
acid	NULL
conferred	NULL
TH	NULL
responsiveness	NULL
to	NULL
this	NULL
reporter	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

The	NULL
PLP	NULL
reporter	NULL
activity	NULL
was	NULL
greatly	NULL
enhanced	NULL
,	NULL
however	NULL
,	NULL
by	NULL
coexpression	NULL
of	NULL
THRB	NULL
and	NULL
PPAR	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TH	NULL
.	NULL

Inclusion	NULL
of	NULL
the	NULL
activator	NULL
of	NULL
PPAR	NULL
was	NULL
not	NULL
necessary	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Surpris-ingly	NULL
,	NULL
THRa	NULL
ยซ	NULL
in	NULL
this	NULL
system	NULL
was	NULL
inactive	NULL
,	NULL
suggesting	NULL
that	NULL
specific	NULL
regulation	NULL
of	NULL
this	NULL
promoter	NULL
requires	NULL
THRB-PPAR	NULL
heterodimers	NULL
.	NULL

Functional	NULL
analyses	NULL
of	NULL
5'-	NULL
and	NULL
3'-deletion	NULL
mutants	NULL
of	NULL
the	NULL
PLP	NULL
promoter	NULL
showed	NULL
that	NULL
PLP-TRE	NULL
resides	NULL
within	NULL
the	NULL
-10	NULL
to	NULL
+52	NULL
fragment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
fragment	NULL
contains	NULL
a	NULL
nearly	NULL
perfect	NULL
DR	NULL
+	NULL
2	NULL
(	NULL
AGGAGAagAGGACA	NULL
)	NULL
at	NULL
position	NULL
+18/	NULL
+31	NULL
within	NULL
the	NULL
untranslated	NULL
region	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
.	NULL

Synthetic	NULL
oligonucleotides	NULL
,	NULL
containing	NULL
the	NULL
wild	NULL
type	NULL
but	NULL
not	NULL
mutated	NULL
sequence	NULL
of	NULL
the	NULL
DR	NULL
+	NULL
2	NULL
,	NULL
conferred	NULL
a	NULL
TH	NULL
response	NULL
to	NULL
a	NULL
TK	NULL
promoter	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
THRB	NULL
and	NULL
PPAR	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Using	NULL
an	NULL
elec-tromobility	NULL
shift	NULL
assay	NULL
only	NULL
THRB-PPAR	NULL
heterodimers	NULL
were	NULL
capable	NULL
of	NULL
forming	NULL
a	NULL
complex	NULL
,	NULL
either	NULL
with	NULL
a	NULL
PLP	NULL
promoter	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
or	NULL
with	NULL
a	NULL
synthetic	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
wt	NULL
but	NULL
not	NULL
mutated	NULL
PLP-TRE	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
formation	NULL
of	NULL
the	NULL
complex	NULL
was	NULL
prevented	NULL
by	NULL
inclusion	NULL
of	NULL
myelin	NULL
basic	NULL
protein	NULL
TRE	NULL
(	NULL
16	NULL
)	NULL
as	NULL
a	NULL
specific	NULL
competitor	NULL
.	NULL

Thus	NULL
,	NULL
THRa	NULL
ยซ	NULL
or	NULL
THRB-RXR	NULL
heterodimers	NULL
recognize	NULL
DR	NULL
+	NULL
4	NULL
(	NULL
3-5	NULL
)	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
THRB-PPAR	NULL
heterodimer	NULL
which	NULL
also	NULL
THRa	NULL
ยซ	NULL
,	NULL
THRB	NULL
,	NULL
and	NULL
PPAR	NULL
Heterodimer	NULL
Coupling	NULL
of	NULL
Signaling	NULL
Pathways	NULL
11685	NULL
1	NULL
AB	NULL
DNA	NULL
Hinge	NULL
LIGAND	NULL
456	NULL
THRB	NULL
_	NULL
[	NULL
|	NULL
[	NULL
TU	NULL
1	NULL
410	NULL
THR	NULL
a	NULL
GOP	NULL
1___	NULL
4695	NULL
456	NULL
Chim	NULL
1	NULL
PPA	NULL
___	NULL
___|	NULL
1	NULL
1777226	NULL
456	NULL
Chim	NULL
2	NULL
Coot	NULL
___|	NULL
1	NULL
227178	NULL
410	NULL
Chim	NULL
3	NULL
[	NULL
___	NULL
___	NULL
Hra	NULL
1	NULL
142/94	NULL
96/146	NULL
456	NULL
Chim	NULL
4	NULL
_	NULL
[	NULL
]	NULL
194/142	NULL
146/96	NULL
410	NULL
Chim	NULL
5	NULL
presence	NULL
of	NULL
THR	NULL
and	NULL
PPAR	NULL
,	NULL
which	NULL
was	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
THR-PPAR	NULL
heterodimers	NULL
on	NULL
TH-dependent	NULL
activation	NULL
of	NULL
ME-TRE-TK-CAT	NULL
and	NULL
TSHf-TRE-TK-CAT	NULL
(	NULL
A	NULL
)	NULL
and	NULL
PPAR	NULL
inhibition	NULL
of	NULL
THR	NULL
interaction	NULL
with	NULL
ME-TRE	NULL
(	NULL
B	NULL
)	NULL
.	NULL

A	NULL
,	NULL
transfection	NULL
assays	NULL
.	NULL

ME-TRE-TK-CAT	NULL
and	NULL
TSHB-TRE-TK-CAT	NULL
reporters	NULL
have	NULL
been	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Transfection	NULL
experiments	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

CAT	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
TH	NULL
induction	NULL
of	NULL
the	NULL
reporter	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
of	NULL
THR	NULL
,	NULL
which	NULL
was	NULL
arbitrarily	NULL
set	NULL
at	NULL
100	NULL
.	NULL

B	NULL
,	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

A	NULL
P-labeled	NULL
ME-TRE	NULL
(	NULL
14	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
and	NULL
and	NULL
PPAR	NULL
were	NULL
generated	NULL
by	NULL
in	NULL
vitro	NULL
reactions	NULL
,	NULL
while	NULL
THRa	NULL
was	NULL
from	NULL
Sf-9	NULL
nuclear	NULL
extract	NULL
.	NULL

Unprogrammed	NULL
lysate	NULL
(	NULL
unpr	NULL
.	NULL

bys	NULL
.	NULL
)	NULL

and	NULL
Sf-9	NULL
wt	NULL
nuclear	NULL
extract	NULL
served	NULL
as	NULL
con-trols	NULL
.	NULL

The	NULL
receptors	NULL
were	NULL
used	NULL
in	NULL
the	NULL
indicated	NULL
combinations	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

arbitrarily	NULL
set	NULL
at	NULL
100	NULL
.	NULL

A	NULL
40	NULL
60	NULL
80	NULL
100	NULL
CAT	NULL
activity	NULL
(	NULL
%	NULL
normalized	NULL
TH	NULL
response	NULL
)	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
thyroid	NULL
hormone	NULL
chimeric	NULL
receptors	NULL
on	NULL
TH-dependent	NULL
transactivation	NULL
of	NULL
PLP-TRE-10/+52-TK-CAT	NULL
reporter	NULL
gene	NULL
.	NULL

Cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
reporter	NULL
PLP-TRE	NULL
(	NULL
-10/+52	NULL
)	NULL
-TK-CAT	NULL
and	NULL
expression	NULL
plasmids	NULL
CMV-PPAR	NULL
together	NULL
with	NULL
RSV-THRa	NULL
or	NULL
RSV-THRB	NULL
or	NULL
RSV-chimera	NULL
1-5	NULL
,	NULL
constructed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
``	NULL
and	NULL
tested	NULL
for	NULL
TH-dependent	NULL
activity	NULL
.	NULL

The	NULL
domains	NULL
of	NULL
the	NULL
receptors	NULL
are	NULL
shown	NULL
above	NULL
the	NULL
top	NULL
bar	NULL
.	NULL

Numbers	NULL
above	NULL
bars	NULL
identify	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
amino	NULL
acids	NULL
in	NULL
THRa	NULL
ยซ	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
and	NULL
B	NULL
(	NULL
hatched	NULL
bars	NULL
)	NULL
.	NULL

Chimera	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
contain	NULL
the	NULL
A/B	NULL
domain	NULL
,	NULL
the	NULL
A/B-DBD	NULL
,	NULL
and	NULL
the	NULL
LBD	NULL
of	NULL
THR	NULL
ยซ	NULL
in	NULL
the	NULL
context	NULL
of	NULL
THR	NULL
,	NULL
respectively	NULL
.	NULL

Chimera	NULL
4	NULL
is	NULL
the	NULL
THRB	NULL
with	NULL
the	NULL
THRa	NULL
D	NULL
box	NULL
;	NULL
chimera	NULL
5	NULL
is	NULL
the	NULL
THRa	NULL
ยซ	NULL
with	NULL
the	NULL
D	NULL
box	NULL
.	NULL

CAT	NULL
activity	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
TH	NULL
induction	NULL
of	NULL
the	NULL
reporter	NULL
in	NULL
the	NULL
Reporter	NULL
:	NULL
ME-TRE-TK-CAT	NULL
Fite	NULL
1007	NULL
807	NULL
607	NULL
407	NULL
Thyroid	NULL
hormone	NULL
response	NULL
(	NULL
%	NULL
)	NULL
THR	NULL
ยซ	NULL
o	NULL
0	NULL
#	NULL
$	NULL
-	NULL
&	NULL
THRB	NULL
moc	NULL
ce	NULL
~	NULL
%	NULL
PPAR	NULL
-o-	NULL
o	NULL
o	NULL
unpr	NULL
.	NULL

lys	NULL
.	NULL

THR	NULL
B	NULL
PPAR	NULL
THR	NULL
a	NULL
Sf9	NULL
wt	NULL
TSHB-TRE-TK-CAT	NULL
1207	NULL
100-80	NULL
607	NULL
40	NULL
204	NULL
11686	NULL
#	NULL
5	NULL
-	NULL
unpr	NULL
.	NULL

lys	NULL
.	NULL

#	NULL
5	NULL
-PPAR	NULL
+	NULL
4	NULL
{	NULL
%	NULL
#	NULL
5-THRoe	NULL
+	NULL
+	NULL
THR	NULL
o	NULL
4	NULL
Sf9	NULL
wt	NULL
ยฃ	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
kDa	NULL
-	NULL
200	NULL
-97	NULL
-	NULL
69	NULL
rage	NULL
:	NULL
0ยฐ	NULL
-s	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Formation	NULL
of	NULL
THR-PPAR	NULL
heterodimers	NULL
in	NULL
solution	NULL
analyzed	NULL
by	NULL
coimmunoprecipitation	NULL
assay	NULL
.	NULL

[	NULL
*ยฐS	NULL
]	NULL
Met-labeled	NULL
PPAR	NULL
and	NULL
THRa	NULL
ยซ	NULL
proteins	NULL
were	NULL
generated	NULL
by	NULL
in	NULL
vitro	NULL
reactions	NULL
,	NULL
and	NULL
unlabeled	NULL
THRa	NULL
ยซ	NULL
was	NULL
from	NULL
Sf-9	NULL
cells	NULL
overexpressing	NULL
this	NULL
receptor	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
coimmunoprecipitation	NULL
reactions	NULL
with	NULL
THRa	NULL
polyclonal	NULL
antiserum	NULL
included	NULL
5	NULL
ul	NULL
of	NULL
in	NULL
vitro	NULL
synthesized	NULL
[	NULL
*S	NULL
)	NULL
Met-labeled	NULL
PPAR	NULL
and	NULL
0.1	NULL
ul	NULL
of	NULL
Sf-9	NULL
nuclear	NULL
extracts	NULL
containing	NULL
THRa	NULL
ยซ	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
[	NULL
ยฐ*ยฐS	NULL
]	NULL
Met	NULL
PPAR	NULL
alone	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
0.1	NULL
pl	NULL
of	NULL
Sf-9	NULL
wt	NULL
extract	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
5	NULL
ul	NULL
of	NULL
[	NULL
*S	NULL
]	NULL
Met	NULL
THRa	NULL
ยซ	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
or	NULL
5	NULL
ul	NULL
each	NULL
of	NULL
[	NULL
*S	NULL
]	NULL
Met	NULL
PPAR	NULL
and	NULL
THRa	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
10	NULL
ul	NULL
of	NULL
[	NULL
*S	NULL
]	NULL
Met	NULL
unprogrammed	NULL
lysate	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

All	NULL
reactions	NULL
contained	NULL
THRa	NULL
ยซ	NULL
polyclonal	NULL
an-tiserum	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
specifically	NULL
coimmunoprecipitated	NULL
PPAR	NULL
.	NULL

recognizes	NULL
DR	NULL
+	NULL
2	NULL
.	NULL

Furthermore	NULL
,	NULL
these	NULL
data	NULL
also	NULL
point	NULL
out	NULL
a	NULL
functional	NULL
difference	NULL
between	NULL
THRa	NULL
and	NULL
THRB	NULL
.	NULL

To	NULL
disclose	NULL
the	NULL
domain	NULL
of	NULL
the	NULL
THRB	NULL
involved	NULL
in	NULL
the	NULL
THRB-PPAR	NULL
heterodimer	NULL
,	NULL
we	NULL
constructed	NULL
several	NULL
chimeric	NULL
receptors	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Chimeras	NULL
1-3	NULL
in	NULL
which	NULL
the	NULL
A/B	NULL
domain	NULL
,	NULL
DBD	NULL
,	NULL
and	NULL
ligand	NULL
binding	NULL
domain	NULL
(	NULL
LBD	NULL
)	NULL
of	NULL
THRa	NULL
ยซ	NULL
and	NULL
THRB	NULL
were	NULL
exchanged	NULL
were	NULL
tested	NULL
for	NULL
TH-dependent	NULL
transactivation	NULL
of	NULL
PLP-TRE-10/+52-TK-CAT	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PPAR	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
A/B	NULL
domain	NULL
(	NULL
chim	NULL
1	NULL
)	NULL
and	NULL
LBD	NULL
(	NULL
chim	NULL
3	NULL
)	NULL
are	NULL
fully	NULL
exchangeable	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
the	NULL
THR	NULL
DBD	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
TH	NULL
response	NULL
(	NULL
chim	NULL
2	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
the	NULL
amino	NULL
acid	NULL
composition	NULL
of	NULL
two	NULL
distinct	NULL
boxes	NULL
in	NULL
a	NULL
nuclear	NULL
hormone	NULL
receptor	NULL
DBD	NULL
might	NULL
be	NULL
sufficient	NULL
to	NULL
determine	NULL
a	NULL
hormone	NULL
response	NULL
element	NULL
specific	NULL
recognition	NULL
(	NULL
18	NULL
)	NULL
.	NULL

THR	NULL
$	NULL
and	NULL
THRa	NULL
ยซ	NULL
share	NULL
the	NULL
same	NULL
proximal	NULL
box	NULL
implicated	NULL
in	NULL
recognition	NULL
of	NULL
the	NULL
primary	NULL
nucleotide	NULL
sequence	NULL
but	NULL
have	NULL
a	NULL
dissimilar	NULL
D	NULL
box	NULL
,	NULL
which	NULL
presumably	NULL
serves	NULL
as	NULL
a	NULL
receptor	NULL
dimerization	NULL
interface	NULL
,	NULL
discriminating	NULL
between	NULL
the	NULL
spacing	NULL
of	NULL
the	NULL
half-sites	NULL
.	NULL

When	NULL
the	NULL
Glu	NULL
,	NULL
Gly	NULL
,	NULL
and	NULL
Lys	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
THRB	NULL
D	NULL
box	NULL
were	NULL
replaced	NULL
by	NULL
Asp	NULL
,	NULL
Ser	NULL
,	NULL
and	NULL
Cys	NULL
of	NULL
the	NULL
THRa	NULL
ยซ	NULL
D	NULL
box	NULL
(	NULL
chim	NULL
4	NULL
)	NULL
,	NULL
TH-dependent	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
reporter	NULL
was	NULL
abolished	NULL
.	NULL

However	NULL
,	NULL
the	NULL
exchange	NULL
of	NULL
the	NULL
THRa	NULL
ยซ	NULL
D	NULL
box	NULL
with	NULL
that	NULL
of	NULL
THRB	NULL
(	NULL
chim	NULL
5	NULL
)	NULL
was	NULL
sufficient	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PPAR	NULL
,	NULL
for	NULL
eliciting	NULL
TH-dependent	NULL
activation	NULL
of	NULL
the	NULL
same	NULL
reporter	NULL
.	NULL

Hence	NULL
,	NULL
THR	NULL
recognizes	NULL
the	NULL
2-nucleotide	NULL
gap	NULL
in	NULL
PLP-TRE	NULL
through	NULL
its	NULL
D	NULL
box	NULL
when	NULL
heterodimerized	NULL
with	NULL
PPAR	NULL
.	NULL

Interestingly	NULL
,	NULL
DR	NULL
+	NULL
2	NULL
can	NULL
confer	NULL
TH	NULL
responsiveness	NULL
by	NULL
discriminating	NULL
between	NULL
THRa	NULL
and	NULL
THRB	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
recep-	NULL
THRa	NULL
,	NULL
THRB	NULL
,	NULL
and	NULL
PPAR	NULL
Heterodimer	NULL
Coupling	NULL
of	NULL
Signaling	NULL
Pathways	NULL
tors	NULL
could	NULL
be	NULL
functionally	NULL
distinct	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
examined	NULL
a	NULL
role	NULL
of	NULL
PPAR	NULL
on	NULL
TH-dependent	NULL
activity	NULL
of	NULL
a	NULL
positive	NULL
,	NULL
DR	NULL
+	NULL
4	NULL
(	NULL
ME	NULL
)	NULL
and	NULL
negative	NULL
,	NULL
DR	NULL
+	NULL
0	NULL
(	NULL
TSH	NULL
)	NULL
TRE	NULL
(	NULL
12	NULL
,	NULL
17	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
coexpression	NULL
of	NULL
PPAR	NULL
,	NULL
either	NULL
with	NULL
THRa	NULL
or	NULL
THRB	NULL
,	NULL
abolished	NULL
the	NULL
TH-dependent	NULL
activation	NULL
and	NULL
inhibition	NULL
of	NULL
ME-TRE-TK-CAT	NULL
and	NULL
TSHB-TRE-TK-CAT	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
negative	NULL
effect	NULL
was	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
formation	NULL
of	NULL
THR-PPAR	NULL
het-erodimers	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
a	NULL
coimmunoprecipitation	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
which	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
THR-RXR	NULL
heterodimers	NULL
(	NULL
14	NULL
)	NULL
,	NULL
can	NULL
not	NULL
interact	NULL
with	NULL
ME-TRE	NULL
(	NULL
DR	NULL
+	NULL
4	NULL
)	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
.	NULL

Since	NULL
both	NULL
RXR	NULL
(	NULL
12	NULL
)	NULL
and	NULL
PPAR	NULL
(	NULL
herein	NULL
)	NULL
can	NULL
abrogate	NULL
TH-dependent	NULL
negative	NULL
regulation	NULL
of	NULL
TSH	NULL
gene	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
PPAR	NULL
is	NULL
mediated	NULL
by	NULL
formation	NULL
of	NULL
inactive	NULL
THR-PPAR	NULL
heterodimers	NULL
rather	NULL
than	NULL
PPAR-RXR	NULL
heterodimers	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
TH	NULL
action	NULL
can	NULL
be	NULL
modulated	NULL
by	NULL
heterodimerization	NULL
of	NULL
PPAR	NULL
with	NULL
THRa	NULL
or	NULL
THRB	NULL
.	NULL

The	NULL
negative	NULL
effect	NULL
of	NULL
PPAR	NULL
appears	NULL
to	NULL
be	NULL
due	NULL
to	NULL
sequestering	NULL
of	NULL
THR	NULL
in	NULL
inactive	NULL
complex	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
.	NULL

A	NULL
different	NULL
steric	NULL
conformation	NULL
of	NULL
the	NULL
two	NULL
heterodimers	NULL
probably	NULL
determines	NULL
that	NULL
only	NULL
THRB-PPAR	NULL
can	NULL
bind	NULL
to	NULL
a	NULL
DR	NULL
+	NULL
2	NULL
.	NULL

This	NULL
represents	NULL
a	NULL
new	NULL
mechanism	NULL
by	NULL
which	NULL
TH	NULL
can	NULL
activate	NULL
genes	NULL
containing	NULL
a	NULL
DR	NULL
+	NULL
2	NULL
and	NULL
provides	NULL
evidence	NULL
for	NULL
coupling	NULL
of	NULL
THR	NULL
and	NULL
PPAR	NULL
signaling	NULL
pathways	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Drs	NULL
.	NULL

Bagchi	NULL
and	NULL
Gonzales	NULL
for	NULL
the	NULL
purified	NULL
and	NULL
the	NULL
rat	NULL
PPAR	NULL
plasmid	NULL
,	NULL
respectively	NULL
,	NULL
Drs	NULL
.	NULL

J.	NULL
Lazar	NULL
and	NULL
B.	NULL
Desvergne	NULL
for	NULL
constructing	NULL
some	NULL
of	NULL
the	NULL
chimeric	NULL
receptors	NULL
,	NULL
and	NULL
Dr.	NULL
D.	NULL
Vannucci	NULL
for	NULL
moral	NULL
support	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Drs	NULL
.	NULL

J.	NULL
Robbins	NULL
and	NULL
J.	NULL
E.	NULL
Rall	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
Dr.	NULL
A.	NULL
Pinchera	NULL
for	NULL
continuous	NULL
encouragement	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Green	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
361	NULL
,	NULL
590-591	NULL
2	NULL
.	NULL

Umesono	NULL
,	NULL
K.	NULL
,	NULL
Murakami	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Thompson	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
65	NULL
,	NULL
1255-1266	NULL
3	NULL
.	NULL

Yu	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
Deisert	NULL
,	NULL
C.	NULL
,	NULL
Andersen	NULL
,	NULL
B.	NULL
,	NULL
Holloway	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Devary	NULL
,	NULL
O.	NULL
V.	NULL
,	NULL
N	NULL
&	NULL
ir	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Kim	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
Boutin	NULL
,	NULL
J-M.	NULL
,	NULL
Glass	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
and	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
67	NULL
,	NULL
1251-1266	NULL
4	NULL
.	NULL

Marks	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Hallenbeck	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Nagata	NULL
,	NULL
T.	NULL
,	NULL
Segars	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Appella	NULL
,	NULL
E.	NULL
,	NULL
Nikodem	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
and	NULL
Ozato	NULL
,	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
1419-1435	NULL
5	NULL
.	NULL

Kliewer	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Umesono	NULL
,	NULL
K.	NULL
,	NULL
Mangelsdorf	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
335	NULL
,	NULL
446-449	NULL
6	NULL
.	NULL

Kliewer	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Umesono	NULL
,	NULL
K.	NULL
,	NULL
Noonan	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Heyman	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
858	NULL
,	NULL
771-774	NULL
7	NULL
.	NULL

Carlberg	NULL
,	NULL
C.	NULL
,	NULL
Bendik	NULL
,	NULL
I.	NULL
,	NULL
Wyss	NULL
,	NULL
A.	NULL
,	NULL
Meier	NULL
,	NULL
E.	NULL
,	NULL
Sturzenbecker	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Grippo	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
Hunziker	NULL
,	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
361	NULL
,	NULL
657-660	NULL
8	NULL
.	NULL

Durand	NULL
,	NULL
B.	NULL
,	NULL
Saunders	NULL
,	NULL
M.	NULL
,	NULL
Leroy	NULL
,	NULL
P.	NULL
,	NULL
Leid	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Chambon	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
71	NULL
,	NULL
73-85	NULL
9	NULL
.	NULL

Issemann	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
347	NULL
,	NULL
645-650	NULL
10	NULL
.	NULL

Dreyer	NULL
,	NULL
C.	NULL
,	NULL
Krey	NULL
,	NULL
G.	NULL
,	NULL
Keller	NULL
,	NULL
H.	NULL
,	NULL
Givel	NULL
,	NULL
F.	NULL
,	NULL
Helftenbein	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Wahli	NULL
,	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
879-887	NULL
11	NULL
.	NULL

Tugwood	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Issemann	NULL
,	NULL
I.	NULL
,	NULL
Anderson	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Bundell	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
McPheat	NULL
,	NULL
W.	NULL
L.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
433-439	NULL
12	NULL
.	NULL

Hallenbeck	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Phyillaier	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Nikodem	NULL
,	NULL
V.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
3825-3828	NULL
13	NULL
.	NULL

Berndt	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Kim	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
and	NULL
Hudson	NULL
,	NULL
L.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
14730-14737	NULL
14	NULL
.	NULL

Hallenbeck	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Marks	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Lippoldt	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Ozato	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nikodem	NULL
,	NULL
V.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
5572-5576	NULL
15	NULL
.	NULL

Sanger	NULL
,	NULL
F.	NULL
,	NULL
Nicklen	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Coulson	NULL
,	NULL
A.	NULL
R.	NULL
(	NULL
1977	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

74	NULL
,	NULL
5463-5467	NULL
16	NULL
.	NULL

Farsetti	NULL
,	NULL
A.	NULL
,	NULL
Mitsuhashi	NULL
,	NULL
T.	NULL
,	NULL
Desvergne	NULL
,	NULL
B.	NULL
,	NULL
Robbins	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Nikodem	NULL
,	NULL
V.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
23226-23232	NULL
17	NULL
.	NULL

Desvergne	NULL
,	NULL
B.	NULL
,	NULL
Petty	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
and	NULL
Nikodem	NULL
,	NULL
V.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
1008-1013	NULL
18	NULL
.	NULL

Umesono	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
57	NULL
,	NULL
1139-1146	NULL

